¨ BCR-ABL1 Kinase Domain Mutation Analysis
Order Code: 333682
CPT Codes: 81403, G0452
Indication : Tyrosine kinase inhibitor drug resistance
Required Patient Information: Clinical Diagnosis
Turn Around Time: 7-10 days
Specimen type: Whole Blood, Bone Marrow
Methodology: Testing for the acquired mutations in the ABL1 kinase domain will be performed by RT-PCR of the BCR-ABL1 translocation followed by nested PCR of the ABL1 kinase domain region and bidirectional sequencing to identify mutations associated with drug resistance.